Abstract
Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first TNF-inhibitor across nine European countries.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have